nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of jejunal hemolymphangioma
|
Xu, Jin |
|
|
55 |
2 |
p. 291-293 |
artikel |
2 |
Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade
|
Elli, Luca |
|
|
55 |
2 |
p. 235-242 |
artikel |
3 |
Comparison of assessment tools in acute upper gastrointestinal bleeding: Which one at which time point?
|
Marmo, Riccardo |
|
|
55 |
2 |
p. 262-267 |
artikel |
4 |
Corrigendum to “Risk of bacterial pneumonia and pneumococcal infection in youths with celiac disease — A population-based study” [Dig Liver Dis 51 (2019) 1101–1105]
|
Canova, Cristina |
|
|
55 |
2 |
p. 303 |
artikel |
5 |
Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges
|
Xin, Jiang |
|
|
55 |
2 |
p. 169-177 |
artikel |
6 |
Detection of potential pathogen in pancreatic fluid aspiration with metagenomic next-generation sequencing in patients with suspected infected pancreatic necrosis
|
Hong, Donghuang |
|
|
55 |
2 |
p. 243-248 |
artikel |
7 |
Editorial Board
|
|
|
|
55 |
2 |
p. i-ii |
artikel |
8 |
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease
|
Melotti, Laura |
|
|
55 |
2 |
p. 230-234 |
artikel |
9 |
Giant gastric myxoid epithelioid gastrointestinal stromal tumor
|
Li, Zonglin |
|
|
55 |
2 |
p. 296-297 |
artikel |
10 |
Gorilla in the room: Even experts can miss polyps at colonoscopy and how AI helps complex visual perception tasks
|
Cherubini, Andrea |
|
|
55 |
2 |
p. 151-153 |
artikel |
11 |
Impact of mismatch repair deficiency on tumour regression grade after neoadjuvant chemotherapy in localized gastroesophageal adenocarcinoma
|
Heran, Maximilien |
|
|
55 |
2 |
p. 276-282 |
artikel |
12 |
Indocyanine green (ICG) fluorescent cholangiography in laparoscopic cholecystectomy: Simplifying time and dose
|
Pardo Aranda, Fernando |
|
|
55 |
2 |
p. 249-253 |
artikel |
13 |
Italian guidelines for the management of irritable bowel syndrome
|
Barbara, Giovanni |
|
|
55 |
2 |
p. 187-207 |
artikel |
14 |
MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular carcinoma
|
Shehab-Eldeen, Somaia |
|
|
55 |
2 |
p. 283-290 |
artikel |
15 |
MiR-21: A potential new target in the treatment strategy of Crohn's disease?
|
Zhao, Yi |
|
|
55 |
2 |
p. 302 |
artikel |
16 |
More evidence is needed on the additional efficacy of vedolizumab as a first-line biologic therapy for inflammatory bowel disease
|
Kakiuchi, Toshihiko |
|
|
55 |
2 |
p. 298-299 |
artikel |
17 |
Pneumatosis cystoides coli associated with intestinal spirochetosis
|
Yamazaki, Kenji |
|
|
55 |
2 |
p. 294-295 |
artikel |
18 |
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
|
Macaluso, Fabio Salvatore |
|
|
55 |
2 |
p. 154-159 |
artikel |
19 |
Reply to comment on: “Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis”
|
Attauabi, Mohamed |
|
|
55 |
2 |
p. 300-301 |
artikel |
20 |
Sensitivity to thyroid hormones is associated with advanced fibrosis in euthyroid patients with non-alcoholic fatty liver disease: A cross-sectional study
|
Li, Ruifang |
|
|
55 |
2 |
p. 254-261 |
artikel |
21 |
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation
|
Rossotti, Roberto |
|
|
55 |
2 |
p. 268-275 |
artikel |
22 |
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
|
Iavarone, Massimo |
|
|
55 |
2 |
p. 160-168 |
artikel |
23 |
The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease
|
Katsanos, Konstantinos H. |
|
|
55 |
2 |
p. 149-150 |
artikel |
24 |
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials
|
Visaggi, Pierfrancesco |
|
|
55 |
2 |
p. 208-222 |
artikel |
25 |
Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease - a retrospective study
|
Livne-Margolin, Moran |
|
|
55 |
2 |
p. 223-229 |
artikel |
26 |
Vascular liver diseases: A sex-oriented analysis of the literature
|
Zanetto, Alberto |
|
|
55 |
2 |
p. 178-186 |
artikel |